TFF Pharmaceuticals Inc (NAS:TFFP)
$ 1.87 0 (0%) Market Cap: 6.48 Mil Enterprise Value: 2.17 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 29/100

Q1 2021 TFF Pharmaceuticals Inc Earnings Call Transcript

May 13, 2021 / 08:30PM GMT
Release Date Price: $212 (-6.81%)
Operator

Thank you for standing by, and welcome to the TFF Pharmaceuticals, Inc. First Quarter 2021 Financial and Business Results Conference Call. (Operator Instructions) As a reminder, today's program may be recorded. And now I'd like to introduce your host for today's program, Paul Sagan, Investor Relations. Please go ahead, sir.

Paul Sagan
LaVoie Strategic Communications Group, Inc. - VP of IR & Corporate Communications

Thank you, operator. Hello, everyone, and welcome to TFF Pharmaceuticals' First Quarter 2021 Financial and Business Results Conference Call. With me on the line today is Glenn Mattes, President and CEO of TFF; Kirk Coleman, Chief Financial Officer; Dr. Dale Christensen, TFF's Director of Clinical Development; Dr. Bill Williams of the University of Texas at Austin; and Chris Cano, TFF's Chief Operating Officer.

A press release announcing our first quarter results is available on the TFF Pharmaceuticals' website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The earnings release and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot